Delivery Order SPE2DR25D2203-SPE2DR26FD2PE
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The delivery order, valued at $33,789.66, represents a firm fixed price contract with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. Performance will occur at the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, valued at $11,989.73, carries a firm fixed price and is classified as a non-set-aside, competitively awarded procurement. The delivery order is scheduled for completion by September 8, 2025, with the place of performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, valued at $3,138.37, was competitively awarded without set-aside designation and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $28,322.36 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competed among qualified vendors through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 19, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injections valued at $7,156.00. The award was made by the Defense Logistics Agency under a firm fixed-price contract structure with no set-aside designation, indicating competitive award status. The order is scheduled for completion by August 20, 2025, with performance at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $11,279.88 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on October 31, 2025, for Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by November 3, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, PA. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. The contract is valued at $15,565.13 with a firm fixed price structure and an ultimate completion date of October 31, 2025. This award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 27, 2025, valued at $8,937.86 for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This competitive, non-set-aside contract is funded through the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by August 28, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $44,346.71 delivery order by the Defense Logistics Agency on June 20, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml formulations. This firm fixed-price delivery order, with an ultimate completion date of June 23, 2025, represents a non-set-aside competitive award and is sourced to the vendor's corporate office location in Conshohocken, PA. The contract does not utilize any small business...